Focused Solutions

The Zeriscope system is a patented web-based mobile technology platform that leverages live interactive video and streaming real-time physiological and environmental sensor data to enable a wide range of new and impactful medical treatments and protocols.

Care View

Provides two-way audio/video for centrally located specialists to perform complete consultations remotely with the help of on-site physician extenders. This simple-to-use and cost-effective solution allows users to increase their footprint.

A link to the video here.

Bio Ware

Provides real time, mobile physiological monitoring, and ecological momentary awareness during PTSD treatment. Therapist visibility and interaction with patients during the in vivo exposure treatment leads to higher treatment response rates and few patient dropouts.

Tele-Trainer

Provides remote experts with multi-dimensional access during Transcranial Doppler Ultrasound training and certification for Sickle Cell Disease treatment and research worldwide. The system is easily tailored to support a wide range of remote hands-on training and certifications requirements.

Zeriscope News

Zeriscope Awarded Grant to Innovate Exposure Therapy Treatment for PTSD

Zeriscope, Inc was awarded a Phase I SBIR Grant from National Institute of Mental Health to develop and test a wearable platform that will allow therapists to virtually accompany PTSD patients during the all-important part of therapy known as “In Vivo Exposure”. This new technology system is expected to increase patients’ willingness to attempt in vivo exercises and to enhance their ability to stay in the situations long enough to obtain therapeutic benefit.

Reducing Stroke Risk in Kids with Sickle Cell Disease

Medical University of South Carolina stroke neurologist Robert J. Adams, M.D., knows firsthand how innovation can bring about dramatic and positive change. He was one of the STOP, Stroke Prevention Trial in Sickle Cell Anemia, investigators who found that transcranial doppler ultrasonography (TCD) could be used to assess stroke risk in children with sickle cell disease (SCD) and stroke risk could be reduced by giving the highest-risk children regular blood transfusions.

Testimonials

” We have been using the device for almost a year now and it is an incredible resource we have, specifically in a rural hospital such as Tuomey, where for several years now we have had an incredibly hard time having on-site neurology being available. They have had tele-neurology, but it has its own limitations, where the physical person is doing the examination. We have successfully use Zeriscope’s Care View to do a full neurology examination on patients at Tuomey. As a result, we have not had the need to transfer patients. “

Souvik Sen, MD, MS, MPH, Neurology
Souvik Sen, MD, MS, MPH, NeurologyPrisma Health Columbia, South Carolina
Sudie Back, PhD
Sudie Back, PhD Professor, Psychiatry and Behavioral Sciences MUSC

“ As a medical professional involved in both research and clinical care for disorders like PTSD, I know how critical real world, in vivo exposure (IVE) sessions are to the successful treatment of PTSD. At present these sessions are unsupervised and “invisible” to the therapist. If there was a way for the therapist to ‘accompany’ the patient virtually and to have both subjective and objective data during IVE, it would be a game-changer by making it possible to optimize IVE in real time …this could lead to improved outcomes with fewer dropouts and lower cost by shortening treatment time. ”

” I am assisting in Transcranial Doppler research training· at sites in the US and abroad. Tele -Trainer allows me to participate without travel and to join other trainers simultaneously instructing a single trainee. Not having to travel opens opportunities I would not otherwise have. Also, when subjects don’t show for the exam, there is minimal disruption to us trainers and we can return to our work rather than waiting around in another city or returning before the job is done. With the camera positions and the ability to see the TCD machine just as if I were in front of it gives me the ability to train as if I was actually there. This technology is what we have needed, and it will decrease costs of travel and time wasted not only from downtime between exams but overnights and travel that can be completely eliminated. That makes a huge difference. “

Toni Mullins, AAS, RVT
Toni Mullins, AAS, RVT Owner/CEO Teach Me TCD LLC
Neurovascular Lab Coordinator
Fenella Kirkham
Fenella Kirkham Professor of Pediatric Neurology
UCL Great Ormond Street Institute of Child Health

“ Our job was to carefully observe how the Transcranial Doppler was being performed, including transducer positioning and movement, in addition to instructing and approving as to how the signals were being displayed and recorded. Tele-Trainer provided two views of the examination, one for each side, as well as a direct feed from the ultrasound machine allowing me to see the settings and the recorded spectra. Not as good as being there, but better than face time by far. “

” I like traveling to train but Covid 19 took that off the table. Using Zeriscope Tele-Trainer I was able to work from Ohio and certify physicians in Lagos and Cairo in research quality TCD. Multiple views and direct input from the Doppler machine provided the information that I needed to instruct and certify. I was also able to very easily “drop in” on sessions being conducted by the other US and UK trainers to compare notes and communicate with examiner and trainer in real time. Although at first it is frustrating not being able to take the probe and show the trainee, perhaps in the long run the result is better. Hard to imagine how we would have managed without Zeriscope. ”

John Bennett PhD, RVT, FICA, NVS 1 1
John Bennett PhD, RVT, FICA, NVS 1 1

Partners

About Zeriscope

Utilizing its patented tele-presence technology platform, Zeriscope delivers creative mobile solutions for diagnosing, treating and caring for patients.  The data captured and analyzed by the Zeriscope platform could lead to early detection, improved outcomes, healthier aging in place, better compliance and reduced healthcare costs. Zeriscope’s design philosophy is centered on simple and easy-to-adopt solutions that leverage smart technology and common-sense healthcare delivery.

Executive Leadership

Bill Harley, Co-Founder and CEO

Bill is an experienced entrepreneur in the healthcare industry, having successfully founded, managed and scaled multiple medical companies. Prior to Zeriscope, Bill founded and led a medical mobility and respiratory equipment company, ultimately overseeing its strategic acquisition to the nation’s largest provider of respiratory services.
Bill serves on the Partnership Board of the McNair Institute for Entrepreneurism and Free Enterprise at the University of South Carolina, holds a degree in Mechanical Engineering from Clemson University and an M.B.A. from the University of South Carolina.

Dr. Robert J. Adams, MS MD, Co-Founder and President

Dr. Adams is the Distinguished University Professor of Neurology at the Medical University of South Carolina and is known as “the Father of Telemedicine for Stroke.” Dr. Adams initiated the REACH MUSC Telestroke Network in 2008, which grew to over 20 sites across the state, dramatically increasing patient access to stroke experts in South Carolina. He has completed over 6000 urgent telemedicine consults for stroke in his venerable career.
In 2013, Dr. Adams recognized the need to expand telemedicine for broader medical usage, and created Zeriscope, an open-access, web-based streaming application that can be used outside of tradition facilities, where cart-based systems are impractical.
Dr. Adams completed medical school at the University of Arkansas College of Medicine, and is a Board Certified Vascular Neurologist.

Discover The Future

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